219649-07-7
219649-07-7
Chemical Structure
Labetuzumab
Synonym(s): hMN14
- CAS No.: 219649-07-7
- Formula:N/A
- Molecular Weight:(145.48 kDa)
SMILES: [Labetuzumab]
Biological Activity: Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Labetuzumab | 99.59% | Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
